|
|
Article: New Study Shows QUADRAMET(R) May Enhance Immune System Recognition of Cancer Cells.
- Article from:
- PR Newswire
- Article date:
- April 4, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Preclinical data presented at AACR indicate that exposure to radiation from QUADRAMET increases the expression of surface molecules involved in the identification and killing of cancer cells by the immune system
Findings indicate that QUADRAMET could enhance immunotherapeutic approaches for the treatment of breast, prostate, lung and other cancers
PRINCETON, N.J., April 4 /PRNewswire-FirstCall/ -- Cytogen Corporation today reported results of a preclinical study indicating that exposure to ionizing radiation with QUADRAMET(R) (samarium Sm-153 lexidronam injection) increases the expression of surface molecules on cancer cells, potentially improving the ...